Lawrence Lauterbach
Psychiatric/Mental Health · Brentwood, TNNPI 1720352040
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $18,838 of the $25,199 with a category attached, or 74.8%. AbbVie accounts for 79.9% of it on its own, with 24 other manufacturers making up the rest. Among psychiatric/mental health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 251 payments — averaging $100.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$20K
- Alkermes, Inc.$804
- Takeda Pharmaceuticals U.S.A., Inc.$740
- Vanda Pharmaceuticals Inc.$715
- Johnson & Johnson$386
- Tris Pharma Inc$348
- plus $2K from 19 others
What the payments were for
- Speaking & faculty fees$18,83875%
- Travel & lodging$3691%
- Food & beverage$5,99324%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $20,135 |
| Alkermes, Inc. | 20 | $804 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $740 |
| Vanda Pharmaceuticals Inc. | 20 | $715 |
| Johnson & Johnson | 13 | $386 |
| Tris Pharma Inc | 14 | $348 |
| Axsome Therapeutics, Inc. | 9 | $332 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $264 |
| Neurocrine Biosciences, Inc. | 7 | $244 |
| Otsuka America Pharmaceutical, Inc. | 12 | $242 |
| Ironshore Pharmaceuticals Inc. | 10 | $177 |
| Eisai Inc. | 5 | $166 |
| Harmony Biosciences LLC | 2 | $137 |
| Lundbeck LLC | 6 | $111 |
| Sunovion Pharmaceuticals Inc. | 5 | $76 |
| Jazz Pharmaceuticals Inc. | 3 | $68 |
| E.r. Squibb & Sons, L.L.C. | 2 | $52 |
| Corium, LLC | 3 | $48 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Alfasigma USA, Inc. | 2 | $29 |
| Boehringer Ingelheim | 1 | $27 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Neos Therapeutics, LP | 1 | $15 |
| Noven Pharmaceuticals, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,199 in reported general payments places this provider in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 13 | $945 |
| Quetiapine Fumarate | 25 | $712 |
| Lamotrigine | 12 | $255 |
| Bupropion Hcl SrBupropion Hcl | 18 | $251 |
| Alprazolam | 12 | $200 |
| Buspirone Hcl | 19 | $195 |
| Clonazepam | 21 | $191 |
| Nortriptyline Hcl | 14 | $155 |
| Zolpidem Tartrate | 12 | $145 |
| Sertraline Hcl | 12 | $23 |
| Fluoxetine Hcl | 12 | $14 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Brentwood
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
- Kristian DambrinoNashville$449K
- Mary AllenMemphis$422K
- Lauren HansenNashville$263K
- Joshua ThompsonChattanooga$262K
- Kristal HurstBlaine$260K
- Kaitlynn EarlsGreeneville$228K
- Tory WoodardCookeville$191K
- Sarah VogelfangerMemphis$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.